5 Nov 2026, 4:40 pmBoard Meeting
Board Meeting Intimation for Board Meeting For Financial Results
Exchange filing PDF
Loading page…
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Anthem Biosciences LimitedANTHEMANTHEM | ₹53,946 Cr | ₹53,997 Cr | ₹2,046 Cr | ₹846 Cr | 39.3% | ₹614 Cr | 27.9% | 27.6% | 19.5% | 124 |
| Advanced Enzyme Technologies LimitedADVENZYMESADVENZYMES | ₹3,175 Cr | ₹3,196 Cr | ₹780 Cr | ₹236 Cr | 30.7% | ₹171 Cr | 23.3% | 13.7% | 11.1% | 331 |
| Ennature Bio Pharma LimitedENNATUREENNATURE | ₹435 Cr | — | — | — | — | — | — | — | — | — |
| CCME Global LtdCCMECCME | ₹54 Cr | ₹54 Cr | ₹0 Cr | ₹0 Cr | — | ₹4 Cr | — | -2.9% | -2.9% | — |
| Vivo Bio Tech LtdVIVOBIOTVIVOBIOT | ₹31 Cr | ₹85 Cr | ₹47 Cr | ₹21 Cr | 44% | ₹7 Cr | 15.6% | 15.2% | 11% | 517 |
| Shree Ganesh Biotech (India) LtdSHREEGANESSHREEGANES | ₹19 Cr | ₹19 Cr | ₹23 Cr | ₹-1 Cr | -19.3% | ₹0 Cr | 7.7% | 0.8% | 0.6% | 846 |
| Genomic Valley Biotech LtdGVBLGVBL | ₹16 Cr | ₹16 Cr | ₹0 Cr | ₹-0 Cr | 14.8% | ₹-1 Cr | 11.1% | 1% | 0.8% | 3,565 |